ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,969.34
0.35%
Dow Jones
44,296.51
0.97%
US Dollar vs MXN
20.4285
0.00%
Brent Oil
74.65
0.00%
Bitcoin
98,515.61
0.75%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Anavex Life Sciences Corporation (AVXL)

  7. Anavex Life Sciences Corporation (AVXL) Noticias

AVXL

Anavex Life Sciences (AVXL)

Anavex Life Sciences Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:AVXL
FechaHoraFuenteTítuloSímboloCompañía
31/10/202403:00GlobeNewswire Inc.Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024NASDAQ:AVXLAnavex Life Sciences Corporation
23/10/202407:03InvestorsHub NewsWireZenaTech, Inc. (NASDAQ: ZENA) Software Company AcquisitionNASDAQ:AVXLAnavex Life Sciences Corporation
17/10/202406:30GlobeNewswire Inc.Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of SchizophreniaNASDAQ:AVXLAnavex Life Sciences Corporation
15/10/202407:21InvestorsHub NewsWireZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory ManagementNASDAQ:AVXLAnavex Life Sciences Corporation
01/10/202406:00InvestorsHub NewsWireZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading TodayNASDAQ:AVXLAnavex Life Sciences Corporation
03/09/202406:30GlobeNewswire Inc.Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024NASDAQ:AVXLAnavex Life Sciences Corporation
06/08/202416:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVXLAnavex Life Sciences Corporation
06/08/202406:30GlobeNewswire Inc.Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business UpdateNASDAQ:AVXLAnavex Life Sciences Corporation
01/08/202406:30GlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
30/07/202416:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVXLAnavex Life Sciences Corporation
30/07/202406:30GlobeNewswire Inc.Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
29/07/202416:21Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AVXLAnavex Life Sciences Corporation
28/07/202416:00GlobeNewswire Inc.Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
20/06/202406:30GlobeNewswire Inc.Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
17/06/202406:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVXLAnavex Life Sciences Corporation
22/05/202406:30GlobeNewswire Inc.Anavex Life Sciences Announces Expansion of Leadership TeamNASDAQ:AVXLAnavex Life Sciences Corporation
14/05/202406:30GlobeNewswire Inc.Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQNASDAQ:AVXLAnavex Life Sciences Corporation
10/05/202404:45PR Newswire (US)Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:AVXLAnavex Life Sciences Corporation
09/05/202406:30GlobeNewswire Inc.Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business UpdateNASDAQ:AVXLAnavex Life Sciences Corporation
07/05/202404:45PR Newswire (US)The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) ShareholdersNASDAQ:AVXLAnavex Life Sciences Corporation
06/05/202405:03Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AVXLAnavex Life Sciences Corporation
03/05/202404:45PR Newswire (US)Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
02/05/202406:30GlobeNewswire Inc.Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024NASDAQ:AVXLAnavex Life Sciences Corporation
26/04/202404:45PR Newswire (US)May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
19/04/202404:45PR Newswire (US)Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL)NASDAQ:AVXLAnavex Life Sciences Corporation
16/04/202404:45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
12/04/202404:45PR Newswire (US)Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:AVXLAnavex Life Sciences Corporation
11/04/202406:30GlobeNewswire Inc.Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity ConferenceNASDAQ:AVXLAnavex Life Sciences Corporation
05/04/202404:45PR Newswire (US)Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
02/04/202404:45PR Newswire (US)Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXLNASDAQ:AVXLAnavex Life Sciences Corporation
 Showing the most relevant articles for your search:NASDAQ:AVXL

Su Consulta Reciente

COIN
SOLUSD
Solana
NYSE
MCD
McDonalds
COIN
XRPUSD
Ripple
CCOM
OILBRENT
Brent Oil
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
AVAXUSD
Avalanche
CCOM
US30
US 30
USI
USTECH100
US Tech 100
COIN
ADAUSD
Cardano
NYSE
CVX
Chevron
COIN
DOGEUSD
Dogecoin
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
NYSE
JPM
JP Morgan Chase
NASDAQ
GOOGL
Alphabet
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados